Trial intelligence / Profile preview

Effect of IV Lignocaine on Desflurane Requirements

NCT06064331Completed

Sponsor
Hospital Canselor Tuanku Muhriz
Start
Jan 2021
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in cholelithiasis, appendicitis, ovarian cyst and 1 more comparing Group Lignocaine with Group Placebo (2 arms). Primary endpoints: End Tidal Desflurane Concentration, Volume of Desflurane used and 1 more. Started Jan 2021; status: completed.

02

Drugs

lidocaine
03

Conditions

cholelithiasisappendicitisovarian cysthernia

Beyond the preview

Go deeper on NCT06064331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06064331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call